Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,825.60
(
-0.49%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
91.36
(
-1.40%
)
Bitcoin
75,239.50
(
1.87%
)
News Focus
News Focus
Post# of 447398
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ziploc_1

Send PM Follow Ignore
Followers 64
Posts 7750
Boards Moderated 1
Alias Born 01/02/2003

ziploc_1

Re: Pharmacydude post# 371373

Monday, 02/21/2022 7:36:09 PM

Monday, February 21, 2022 7:36:09 PM

Post# of 447398
From SA..."Vascepa will likely be approved in China by the end of 2021, based on several clinical studies confirming the efficacy and safety of this medicine."...

What's up with the delay?...Is price holding up the approval of Vascepa in China?...With over 100 million people in China able to profit from taking Vascepa...i.e. by having a reduction in CVD, Amarin can afford to negotiate a lower price for China.





Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News